| Financial Year |
March 31 2023 |
| Monetary Funds |
155,451,897.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,460,637.34 |
| Accounts Receivable |
130,533,542.83 |
| Advances to Suppliers |
62,329,543.71 |
| Other Receivables |
2,327,084.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
41,284,817.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,127,500.00 |
| Other Current Assets |
4,544,638.54 |
| Total Current Assets |
409,059,661.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
95,824,599.79 |
| Under-construction Projects |
269,533.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,351,979.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,771,313.56 |
| Deferred Income Tax Assets |
26,415,846.28 |
| Other Non-Current Assets |
27,932,922.72 |
| Sub-Total of Non-Current Assets |
200,725,168.70 |
| Total Assets |
609,784,830.29 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,896,691.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,018,628.62 |
| Taxes Payable |
204,501.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,429,518.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
870,187.36 |
| Other Current Liabilities |
2,006,491.94 |
| Sub-Total of Current Liabilities |
104,864,205.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,429,326.27 |
| Total Liabilities |
107,293,531.88 |
| Paid-In Capital(Or Share Stock) |
362,314,440.00 |
| Capital Surplus |
9,624,394.83 |
| Surplus Reserve |
23,233,434.63 |
| LESS:Treasury Stock |
771,850.00 |
| Undistributed Profits |
78,530,143.36 |
| Minority Stockholder's Interest |
6,951,459.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
495,539,838.54 |
| Owner's Equity（Stockholder's Equity） |
502,491,298.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
609,784,830.29 |
